Regenerative Repair and Medicine

Cell Therapy and Regenerative Medicine Market

Global public healthcare payers are exerting significant pricing pressure as governments work to close budget shortfalls. By decreasing the need for long-term care and the related problems, regenerative medicine may be able to save public health organisations money. This could have positive effects on the global economy as well. The tissue engineering and regeneration products market reached over $55.9 billion globally in 2010 and it is projected to grow to $135 billion by 2024.